Literature DB >> 3039366

Experience with itraconazole in deep mycoses in northern Italy.

M A Viviani, A M Tortorano, R Woenstenborghs, G Cauwenbergh.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1987        PMID： 3039366     DOI： 10.1111/j.1439-0507.1987.tb03973.x

Source DB:  PubMed          Journal:  Mykosen        ISSN： 0027-5557


× No keyword cloud information.
  8 in total

Review 1.  Combination therapy for systemic mycosis.

Authors:  A Polak
Journal:  Infection       Date:  1989 Jul-Aug       Impact factor: 3.553

Review 2.  Sporothrix schenckii var luriei as the cause of sporotrichosis in Italy.

Authors:  F Alberici; C T Paties; G Lombardi; L Ajello; L Kaufman; F Chandler
Journal:  Eur J Epidemiol       Date:  1989-06       Impact factor: 8.082

Review 3.  Nosocomial aspergillosis: environmental microbiology, hospital epidemiology, diagnosis and treatment.

Authors:  T J Walsh; D M Dixon
Journal:  Eur J Epidemiol       Date:  1989-06       Impact factor: 8.082

Review 4.  Cryptococcosis in the era of AIDS--100 years after the discovery of Cryptococcus neoformans.

Authors:  T G Mitchell; J R Perfect
Journal:  Clin Microbiol Rev       Date:  1995-10       Impact factor: 26.132

Review 5.  Itraconazole. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in superficial and systemic mycoses.

Authors:  S M Grant; S P Clissold
Journal:  Drugs       Date:  1989-03       Impact factor: 9.546

6.  Treatment of experimental cryptococcosis with SCH 39304 and fluconazole.

Authors:  R Negroni; M R Costa; J L Finquelievich; C Iovannitti; I Agorio; I N Tiraboschi; D Loebenberg
Journal:  Antimicrob Agents Chemother       Date:  1991-07       Impact factor: 5.191

7.  Primary lymph node invasive aspergillosis.

Authors:  A Mazzoni; M Ferrarese; R Manfredi; A Facchini; C Sturani; A Nanetti
Journal:  Infection       Date:  1996 Jan-Feb       Impact factor: 3.553

Review 8.  Tissue penetration of antifungal agents.

Authors:  Timothy Felton; Peter F Troke; William W Hope
Journal:  Clin Microbiol Rev       Date:  2014-01       Impact factor: 26.132
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.